Townsquare Capital LLC Invests $544,000 in Solventum Co. (NYSE:SOLV)

Townsquare Capital LLC bought a new position in shares of Solventum Co. (NYSE:SOLV - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 7,800 shares of the company's stock, valued at approximately $544,000.

A number of other hedge funds also recently modified their holdings of the stock. EverSource Wealth Advisors LLC bought a new position in shares of Solventum in the 1st quarter valued at $30,000. GAMMA Investing LLC acquired a new position in Solventum during the 2nd quarter worth approximately $74,000. Massmutual Trust Co. FSB ADV bought a new position in Solventum in the 2nd quarter valued at approximately $34,000. DNB Asset Management AS acquired a new stake in Solventum in the second quarter valued at approximately $1,227,000. Finally, CWM LLC acquired a new stake in Solventum in the second quarter valued at approximately $473,000.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Mizuho assumed coverage on Solventum in a research note on Wednesday. They issued a "neutral" rating and a $70.00 price target for the company. Stifel Nicolaus started coverage on Solventum in a research note on Tuesday, October 8th. They set a "buy" rating and a $82.00 price target on the stock. Morgan Stanley boosted their price target on Solventum from $60.00 to $73.00 and gave the stock an "equal weight" rating in a report on Monday, November 11th. Piper Sandler raised their price objective on shares of Solventum from $71.00 to $75.00 and gave the company a "neutral" rating in a report on Friday, November 8th. Finally, The Goldman Sachs Group boosted their target price on shares of Solventum from $48.00 to $54.00 and gave the stock a "sell" rating in a report on Monday, August 12th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $68.29.

Solventum Trading Down 1.0 %

Solventum stock traded down $0.70 during mid-day trading on Thursday, hitting $69.56. 845,240 shares of the stock were exchanged, compared to its average volume of 1,673,251. The firm's fifty day simple moving average is $70.65 and its two-hundred day simple moving average is $62.82. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. Solventum Co. has a 12 month low of $47.16 and a 12 month high of $96.05.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.